Lifeline for cancer patients: continued access to targeted drug crizotinib
NCT ID NCT05160922
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 22 times
Summary
This study offers continued access to the drug crizotinib for people with certain cancers (NSCLC, ALCL, or IMT) who are already benefiting from it in another Pfizer study that is ending. About 27 participants will be enrolled to receive ongoing treatment and to monitor safety. The goal is to keep providing a treatment that works for them, not to test a new cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Monza
Monza, MB, 20900, Italy
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Cancer Hospital Chinese Academy of Medical Science
Beijing, Beijing Municipality, 100021, China
-
Fujian Province Oncology Hospital
Fuzhou, Fujian, 350014, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130028, China
-
Limited Liability Company "EuroCityClinic"
Saint Petersburg, 197022, Russia
-
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001, Japan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Shanghai Chest Hospital
Shanghai, 200030, China
-
Sun Yat-Sen University Cancer center
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of College of Medicine,Zhejiang University
Hangzhou, Zhejiang, 310003, China
-
The First Affiliated Hospital of Guangzhou Medical University.
Guangzhou, Guangzhou, 510120, China
-
West China Hospital of Sichuan University
Wuhou District, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.